AliveCor QT Service vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

Tool A specializes in precise QT/QTc interval measurements from AliveCor 6-Lead ECGs, primarily for cardiac safety and medication prescribing decisions. In contrast, Tool B offers a broader AI-powered diagnostic analysis for 12-lead resting ECGs, identifying a wider range of cardiovascular diseases. While both utilize AI for ECG interpretation, their distinct focus areas and compatible ECG types make them suitable for different clinical needs.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is rapid, accurate QT and QTc interval measurement from AliveCor 6-Lead ECGs to inform medication prescribing decisions and enhance cardiac safety. This cloud-based SaMD is ideal for healthcare professionals managing patients where drug-induced QT prolongation is a concern, leveraging AI for instant analysis of ambulatory ECG data.

View AliveCor QT Service →

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if you require a comprehensive, AI-powered automatic analysis and diagnosis system for standard 12-lead resting ECGs, compatible with various ECG machines. This platform is best suited for physicians needing rapid (approximately 3 seconds) and highly accurate diagnoses of a wide range of cardiovascular conditions, including arrhythmias, myocardial ischemia, and infarction, across different clinical settings.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service AI-ECG Platform
Pricing Varies by product and service, with subscription options available. Contact for pricing
Deployment Mobile app, cloud-based platform, EHR integration. Workstation (with GPU), web-based portal, Windows-based diagnostic client
BAA Available Yes AI-estimated Unknown
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AliveCor QT Service

Tool A, the AliveCor QT Service, offers a streamlined, cloud-based approach integrated with existing AliveCor platforms like KardiaStation and KardiaPro. Its focus on instant QT measurements from ambulatory 6-Lead ECGs suggests a user-friendly workflow for point-of-care and mobile settings, enhancing ease of use for healthcare professionals.

Clinical Value

AI-ECG Platform

Tool B, the AI-ECG Platform, provides broader clinical value by offering an FDA-cleared automatic analysis and diagnosis system for 12-lead resting ECGs. It diagnoses a wider range of major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with over 95% accuracy, addressing a more comprehensive set of cardiology needs compared to Tool A's specialized QT interval measurement.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing details, making it impossible to directly compare their cost-effectiveness or overall value. Without transparent pricing information for either product, a definitive winner cannot be determined in this dimension.

Enterprise Readiness

AliveCor QT Service

Tool A demonstrates stronger enterprise readiness with explicit statements of HIPAA compliance and the availability of a Business Associate Agreement (BAA). Furthermore, it offers an API for integration with various enterprise systems such as EHR, SDK, CRM, EDC, and PSP platforms, facilitating seamless adoption within complex healthcare IT environments.

Innovation

AI-ECG Platform

Tool B exhibits a higher degree of innovation through its hardware-independent design, allowing compatibility with most existing ECG machines and supporting various ECG data formats (Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG). This broad interoperability significantly reduces adoption barriers and enhances its applicability across diverse clinical settings, while also providing rapid diagnoses in approximately 3 seconds.

Support & Docs

AliveCor QT Service

AliveCor, the company behind Tool A, has an established presence and a comprehensive support infrastructure for its product lines, including professional services. Publicly available information suggests more structured and accessible support resources for AliveCor products, whereas specific details regarding extensive documentation or dedicated support portals for Shenzhen Carewell Electronics' AI-ECG Platform are not as readily apparent on public-facing channels.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service AI-ECG Platform
Name AliveCor QT Service AI-ECG Platform
Company AliveCor Shenzhen Carewell Electronics Co., Ltd.
Description A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. An FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
Key Features Cloud-based Software as a Medical Device (SaMD), Measures QT and QTc intervals (Bazett's and Fridericia's formulas), Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L), Prescription (Rx) use only, for qualified healthcare professionals, Utilizes AI and deep neural networks for ECG analysis, Provides instant QT measurements (as InstantQT), Integrates with KardiaStation app and KardiaPro portal, API available for integration with EHR, SDK, CRM, EDC, and PSP platforms AI-powered automatic ECG analysis and diagnosis, Over 95% accuracy in diagnosing major cardiovascular diseases, Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, Hardware independent, compatible with most ECG machines, Web-based Management Portal for organization settings, security, and task management, AI-ECG Diagnostic Client for professional ECG review, waveform measurement, and report generation, Rapid diagnosis in approximately 3 seconds, Supports various ECG data formats: Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG
ECG Leads Analyzed 6-Lead ECGs 12-lead resting ECGs
Specific Measurements/Diagnoses QT and QTc interval measurements (Bazett's and Fridericia's formulas). Arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Integration Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms. Compatible with most ECG machines; Supports various ECG data formats: Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG.

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and AI-ECG Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service (Tool A) focuses specifically on instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. In contrast, the AI-ECG Platform (Tool B) provides AI-powered automatic analysis and diagnosis for 12-lead resting ECGs, designed to assist physicians in interpreting and diagnosing conditions such as arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
AliveCor QT Service (Tool A) analyzes ECGs exclusively from AliveCor 6-Lead ambulatory ECG devices, such as KardiaMobile 6L. The AI-ECG Platform (Tool B) is hardware independent and compatible with most ECG machines, supporting various data formats including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG.
AliveCor QT Service (Tool A) specifically measures QT and QTc intervals using Bazett's and Fridericia's formulas to assess cardiac safety and inform medication prescribing decisions. The AI-ECG Platform (Tool B) diagnoses a broader range of conditions, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with over 95% accuracy in diagnosing major cardiovascular diseases.
AliveCor QT Service (Tool A) integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. The AI-ECG Platform (Tool B) includes a Web-based Management Portal for organization settings, security, and task management, and an AI-ECG Diagnostic Client for professional ECG review, waveform measurement, and report generation.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.